(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide

C50H56N8O8S — CID 143154005

IUPAC(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide
SMILESC/C=C(\C=C(/C)Cn1c(C)nc2cc(C3=NN(Cc4csc(CNC(=O)[C@H](O)[C@@H](O)C(=O)N5Cc6ccccc6C5)c4)C(C)C3)ccc21)CNC(=O)[C@H](O)[C@@H](O)C(=O)N1Cc2ccccc2C1
InChIInChI=1S/C50H56N8O8S/c1-5-32(20-51-47(63)43(59)45(61)49(65)55-24-35-10-6-7-11-36(35)25-55)16-29(2)22-57-31(4)53-41-19-34(14-15-42(41)57)40-17-30(3)58(54-40)23-33-18-39(67-28-33)21-52-48(64)44(60)46(62)50(66)56-26-37-12-8-9-13-38(37)27-56/h5-16,18-19,28,30,43-46,59-62H,17,20-27H2,1-4H3,(H,51,63)(H,52,64)/b29-16+,32-5+/t30?,43-,44-,45-,46-/m1/s1
InChIKeyGNQMULLZOOKIOB-LPELWIFXSA-N
MW929.11 g/mol
LogP3.56
Rot. Bonds16

About (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide

(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide (PubChem CID 143154005) has the molecular formula C50H56N8O8S and a molecular weight of 929.11 g/mol. Its IUPAC name is (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide.

Molecular Properties

Compound Name(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide
PubChem CID143154005
Molecular FormulaC50H56N8O8S
Molecular Weight929.11 g/mol
Exact Mass928.39
IUPAC Name(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide
SMILESC/C=C(\C=C(/C)Cn1c(C)nc2cc(C3=NN(Cc4csc(CNC(=O)[C@H](O)[C@@H](O)C(=O)N5Cc6ccccc6C5)c4)C(C)C3)ccc21)CNC(=O)[C@H](O)[C@@H](O)C(=O)N1Cc2ccccc2C1
InChIInChI=1S/C50H56N8O8S/c1-5-32(20-51-47(63)43(59)45(61)49(65)55-24-35-10-6-7-11-36(35)25-55)16-29(2)22-57-31(4)53-41-19-34(14-15-42(41)57)40-17-30(3)58(54-40)23-33-18-39(67-28-33)21-52-48(64)44(60)46(62)50(66)56-26-37-12-8-9-13-38(37)27-56/h5-16,18-19,28,30,43-46,59-62H,17,20-27H2,1-4H3,(H,51,63)(H,52,64)/b29-16+,32-5+/t30?,43-,44-,45-,46-/m1/s1
InChIKeyGNQMULLZOOKIOB-LPELWIFXSA-N
XLogP3.56
TPSA213.16 Ų
H-Bond Donors6
H-Bond Acceptors13
Rotatable Bonds16
Heavy Atoms67
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500929.11
LogP ≤ 53.56
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide?
The IUPAC name of (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide (CID 143154005) is (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide.
What is the SMILES notation for (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide?
The canonical SMILES for (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide is C/C=C(\C=C(/C)Cn1c(C)nc2cc(C3=NN(Cc4csc(CNC(=O)[C@H](O)[C@@H](O)C(=O)N5Cc6ccccc6C5)c4)C(C)C3)ccc21)CNC(=O)[C@H](O)[C@@H](O)C(=O)N1Cc2ccccc2C1.
What is the InChIKey of (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide?
The InChIKey is GNQMULLZOOKIOB-LPELWIFXSA-N. The full InChI is InChI=1S/C50H56N8O8S/c1-5-32(20-51-47(63)43(59)45(61)49(65)55-24-35-10-6-7-11-36(35)25-55)16-29(2)22-57-31(4)53-41-19-34(14-15-42(41)57)40-17-30(3)58(54-40)23-33-18-39(67-28-33)21-52-48(64)44(60)46(62)50(66)56-26-37-12-8-9-13-38(37)27-56/h5-16,18-19,28,30,43-46,59-62H,17,20-27H2,1-4H3,(H,51,63)(H,52,64)/b29-16+,32-5+/t30?,43-,44-,45-,46-/m1/s1.
What are the key properties of (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide?
(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide has a molecular weight of 929.11 g/mol, XLogP of 3.56, 16 rotatable bonds, 6 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3R)-4-(1,3-dihydroisoindol-2-yl)-N-[[4-[[5-[1-[(2E,4E)-4-[[[(2R,3R)-4-(1,3-dihydroisoindol-2-yl)-2,3-dihydroxy-4-oxobutanoyl]amino]methyl]-2-methylhexa-2,4-dienyl]-2-methylbenzimidazol-5-yl]-3-methyl-3,4-dihydropyrazol-2-yl]methyl]thiophen-2-yl]methyl]-2,3-dihydroxy-4-oxobutanamide is sourced from PubChem (CID 143154005), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).